- Home
- GAIA vs LXRX Comparison
GAIA vs LXRX Comparison
Compare GAIA & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIA
- LXRX
- Stock Information
- Founded
- GAIA 1988
- LXRX 1995
- Country
- GAIA United States
- LXRX United States
- Employees
- GAIA N/A
- LXRX N/A
- Industry
- GAIA Movies/Entertainment
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- GAIA Consumer Discretionary
- LXRX Health Care
- Exchange
- GAIA Nasdaq
- LXRX Nasdaq
- Market Cap
- GAIA 104.1M
- LXRX 124.4M
- IPO Year
- GAIA 1999
- LXRX 2000
- Fundamental
- Price
- GAIA $3.92
- LXRX $0.46
- Analyst Decision
- GAIA Strong Buy
- LXRX Buy
- Analyst Count
- GAIA 2
- LXRX 4
- Target Price
- GAIA $8.00
- LXRX $3.67
- AVG Volume (30 Days)
- GAIA 31.2K
- LXRX 30.7M
- Earning Date
- GAIA 05-05-2025
- LXRX 03-06-2025
- Dividend Yield
- GAIA N/A
- LXRX N/A
- EPS Growth
- GAIA N/A
- LXRX N/A
- EPS
- GAIA N/A
- LXRX N/A
- Revenue
- GAIA $90,363,000.00
- LXRX $31,081,000.00
- Revenue This Year
- GAIA $14.66
- LXRX N/A
- Revenue Next Year
- GAIA $16.14
- LXRX $101.91
- P/E Ratio
- GAIA N/A
- LXRX N/A
- Revenue Growth
- GAIA 12.36
- LXRX 2481.48
- 52 Week Low
- GAIA $3.18
- LXRX $0.28
- 52 Week High
- GAIA $6.53
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- GAIA 39.53
- LXRX 50.39
- Support Level
- GAIA $3.68
- LXRX $0.32
- Resistance Level
- GAIA $4.05
- LXRX $0.71
- Average True Range (ATR)
- GAIA 0.18
- LXRX 0.06
- MACD
- GAIA 0.01
- LXRX 0.03
- Stochastic Oscillator
- GAIA 36.36
- LXRX 36.95
About GAIA Gaia Inc.
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.